Compare CECO & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CECO | INDV |
|---|---|---|
| Founded | 1966 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pollution Control Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.7B |
| IPO Year | 2002 | 2014 |
| Metric | CECO | INDV |
|---|---|---|
| Price | $75.39 | $34.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $80.25 | N/A |
| AVG Volume (30 Days) | 676.0K | ★ 1.8M |
| Earning Date | 04-28-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 280.56 | ★ 8100.00 |
| EPS | N/A | ★ 1.67 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $24.84 | N/A |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | ★ N/A | $20.82 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $42.85 | $22.22 |
| 52 Week High | $101.24 | $42.81 |
| Indicator | CECO | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 52.27 | 31.88 |
| Support Level | $74.17 | $32.06 |
| Resistance Level | $83.24 | $35.54 |
| Average True Range (ATR) | 3.46 | 0.96 |
| MACD | 0.83 | -0.08 |
| Stochastic Oscillator | 54.57 | 10.04 |
CECO Environmental Corp is an industrial company, serving industrial air, industrial water, and energy transition markets. It offers various engineered and configured products and solutions, including dampers and diverters, selective catalytic reduction systems, severe-service and industrial cyclones, dust collectors, thermal oxidizers, filtration systems, wet and dry scrubbers, water treatment packages, industrial silencers, etc. These products are offered through brands like Western Airducts, WK, Wakefield Acoustics, Transcend, Verantis, and others. The company's reportable segments are: Engineered Systems, which derive maximum revenue, and Industrial Process Solutions. Geographically, it derives key revenue from the U.S., followed by the Netherlands, the UK, China, and other markets.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).